Molecular Templates raises $8.5m to fund lymphoma trial
This article was originally published in Scrip
Executive Summary
Privately held biopharmaceutical firm, Molecular Templates has raised $8.5m to fund Phase I clinical trials of its non-Hodgkin's lymphoma therapy.